Geffen Aud/Fr M17

Michelle Mielke, Ph.D.
"Sphingolipids: Common Pathway for Multiple Neurodegenerative Diseases"

Learning objectives:
Identify multiple neurodegenerative diseases associated with the sphingolipid pathway
Review the translational work relating the sphingolipid pathway, from cells to humans, for Alzheimer's disease and Parkinson's disease
Describe how plasma sphingolipids could be utilized as biomarkers for Alzheimer's disease or Parkinson's disease

The presenter (and/or spouse/partner) has the following relevant financial relationship to disclose: Consultant - Lysosomal Therapeutics, Inc,  Eli Lilly; Grant/Research Support - NIH/NIA, DoD, Michael J. Fox Foundation, and unrestricted research grants from Biogen, Roche, and Lundbeck
The presenter does not intend to discuss an off-label/investigative use of a commercial product/device.